戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                                       There was a lower incidence of influenza-related complications in t
2 Whilst no protective effect of rosuvastatin was seen, there was a lower than expected level of nephrotoxicity in the coho
3                       The rate of all-cause hospitalization was also lower following sensor implantation (1.67 versus 2.2
4                                     The second TC incidence was also lower for those age >= 30 years (2.8%; 95% CI, 2.3 t
5                                          The ratio of PC/PE was clearly lower in HH group indicating a shift from PC to P
6 l phenolic compounds varied, their total content in berries was considerably lower (76.1-205.2 mg.kg(-1)) than in leaves
7  high expression was seen in liver biopsies, but expression was considerably lower in skeletal muscles.
8            Lanadelumab efficacy was durable-HAE attack rate was consistently lower vs placebo, from the first 2 weeks of
9        The risk of an elevated viral load (>=400 copies/mL) was independently lower among participants with baseline CD4
10            In stress models, inflammatory cell infiltration was initially lower in knockout mice but later increased, lea
11  high specificity for all IE subtypes; however, sensitivity was markedly lower for native valve IE than prosthetic valve
12                   The radical concentration in e-cigarettes was much lower as compared to tobacco TPM.
13      It is likely that the dose of rehabilitation delivered was much lower than dictated by the protocol in many randomiz
14 imination performance obtained for large variations in size was no lower than that obtained for smaller variations in siz
15 he risk of the composite of recurrent VTE or major bleeding was nonsignificantly lower with DOACs than with LMWHs (RR, 0.
16 nalysis comprising 2607 patients, the risk of recurrent VTE was nonsignificantly lower with DOACs than with LMWHs (RR, 0.
17                                         All-cause mortality was significant lower in the ICD group (5% versus 13%, hazard
18 he control group, and the probability of asthma development was significantly lower.
19                                                         CCT was significantly lower after DMEK-only than after triple-DME
20                                 The amplitude of activation was significantly lower after infarct and demonstrated a patt
21                                      Antibiotic prescribing was significantly lower among patients who received an initia
22                                             The rate of HFH was significantly lower at 1 year compared with the year befo
23         The participation rate in the control group (17.5%) was significantly lower compared with the sequential (25.8%)
24                                                 However, it was significantly lower for 2 (16.4 vs 29.4), or 3 injections
25                                   Spending on index surgery was significantly lower for EVR (median [interquartile range]
26                                 Within-treatment dispersion was significantly lower for salt and nutrient addition microc
27 nce, the positive-predictive value toward ICM configuration was significantly lower for segmental as compared to whole-ch
28                          IPD incidence in children <5 years was significantly lower for serotypes 1 (incidence rate ratio
29                        The volume of the surgical specimens was significantly lower in Group B than in Group A (128.68cm3
30                                       Median length of stay was significantly lower in LB group (2.0 versus 3.0; adjusted
31                      The median washout coefficient (K (2)) was significantly lower in malignant lesions than in benign l
32 n the 20-mg, 10-mg, and 5-mg groups, respectively; the risk was significantly lower in the 10-mg group than in the 20-mg
33                                 In comparison, the recovery was significantly lower in the bread sample.
34 years of follow-up (n = 1,775, 9 RCTs), all-cause mortality was significantly lower in the DCB group when compared with c
35                                           [(11)C]UCB-J V(T) was significantly lower in the frontal and anterior cingulate
36                               Colon expression of alpha-SMA was significantly lower in the MODULEN group versus controls
37                                               Serum miR-375 was significantly lower in the peritoneal pouch group than in
38 riencing out-of-hospital cardiac arrest, discharge survival was significantly lower in women than in men, especially amon
39 the slope of the fascicle gear ratio over ankle joint angle was significantly lower on the paretic side.
40 ies was 4.7% (95% confidence interval [CI], 3.6-6.1), which was significantly lower than at baseline (18.7%; relative red
41 DR of PERFORMS outliers was 7.2 per 1000 women screened and was significantly lower than other readers (nonoutliers) wher
42                          The yield of routine protocol EMBs was significantly lower than symptom-triggered EMBs, not only
43 kely pathogenic variants in ATP13A2, PLA2G6, PRKN, or PINK1 was significantly lower than that of non-carriers, while the
44 >=1.00 IU/mL QFT, >=8 spots TSPOT), TST and QFT specificity was significantly lower than TSPOT.
45 ly, the proportion of flies dying after M. luteus infection was significantly lower when flies were fed a low-P high-C di
46                  During days 0-69, mean monthly attack rate was significantly lower with lanadelumab (0.41-0.76) vs place
47  ~2000 when it reached its highest point to date of 75%; it was slightly lower at 73% in 2018.
48                            The NPA for the EDTA-CBDE method was slightly lower at 94.2% with Enterobacterales, whereas it
49 en though the recovery of GlcN from spiked cricket material was slightly lower compared to that using spectrophotometric
50                           Moreover, proteoglycan expression was slightly lower in the mitral valves of MVP patients treat